Abstract
In this prospective multicenter study, we investigated the course of depression and anxiety during hematopoietic stem cell transplantation (HSCT) until 5 years after transplantation adjusting for medical information. Patients were consulted before HSCT (n=239), at 3 months (n=150), 12 months (n=102) and 5 years (n=45) after HSCT. Depression and anxiety were assessed with the Hospital Anxiety and Depression Scale (HADS). Detailed medical and demographic information was collected. Prevalence rates were compared with an age- and gender-matched control group drawn from a large representative sample (n=4110). The risk of depression before HSCT was lower for patients than for the control group (risk ratio (RR), 0.56; 95% confidence interval (CI), 0.39/0.81). Prevalence rates of depression increased from 12 to 30% until 5 years post HSCT. Anxiety rates were most frequently increased before HSCT (29%, RR, 1.31; 95% CI, 1.02/1.68) and then reached a stable level comparable to the background population (RR 0.83, 95% CI, 0.56/1.22). This study confirms the low levels of depression in the short term after HSCT and identifies depression as a long-term effect. Furthermore, it confirms previous results of heightened anxiety before HSCT. Surveillance of symptoms of anxiety during the short-term phase of HSCT and of depression during the following years is crucial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.
Fife BL, Fausel CA. Hematopoietic dyscrasias and stem cell/bone marrow transplantation. In: Holland JC (ed). Psycho-oncology, 2nd edn, Oxford University Press: New York, NY, USA, 2010, pp 191–195..
Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN . Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009; 18: 113–127.
Goetzmann L, Boehler A, Halter J, Klaghofer R, Muellhaupt B, Wagner-Huber R et al. Quality of life and psyschosocial situation before and after a lung, liver or an allogeneic bone marrow transplant: results from a prospective study. Swiss Med Wkly 2006; 136: 281–290.
Prieto JM, Atala J, Blanch J, Carreras E, Rovira M, Cirera E et al. Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. Bone Marrow Transplant 2005; 35: 307–314.
Hjermstad MJ, Loge JH, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S . The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219–1228.
Illescas-Rico R, Amaya-Ayala F, Jiménez-López JL, Caballero-Méndez ME, González-Llaven J . Increased incidence of anxiety and depression during bone marrow transplantation. Arch Med Res 2002; 33: 144–147.
Syrjala KL, Langer SL, Abrams JR, Storer BE, Martin PJ . Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005; 23: 6596–6606.
Andrykowski MA, Bishop MM, Hahn EA, Cella D, Beaumont JL, Brady MJ et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 2005; 23: 599–608.
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers, Mary ED et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004; 291: 2335–2343.
Chang G, Orav J, Mcnamara TK, Tong M, Antin JH . Psychosocial function after hematopoietic stem cell transplantation. Psychosomatics 2005; 46: 34–40.
Broers S, Kaptein AA, Le Cessie S, Fibbe W, Hengeveld MW . Psychological functioning and quality of life following bone marrow transplantation: a 3-year follow-up study. J Psychosom Res 2000; 48: 11–21.
Rischer J, Scherwath A, Zander AR, Koch U, Schulz-Kindermann F . Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant 2009; 44: 121–128.
Beglinger LJ, Duff K, Van Der Heiden, Sara, Moser DJ, Bayless JD, Paulsen JS et al. Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: a preliminary study. J Int Neuropsychol Soc 2007; 13: 172–177.
Hjermstad MJ, Knobel H, Brinch L, Fayers PM, Loge JH, Holte H et al. A prospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004; 34: 257–266.
Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.
Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303: 47–53.
Scherwath A, Schirmer L, Kruse M, Ernst G, Eder M, Dinkel A et al. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study. Psychooncology 2013; 22: 1509–1516.
Hinz A, Brähler E . Normative values for the hospital anxiety and depression scale (HADS) in the general German population. J Psychosom Res 2011; 71: 74–78.
Zigmond AS, Snaith RP . The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.
Hermann C, Buss U, Snaith RP . Hospital Anxiety and Depression Scale – Deutsche Version (HADS-D). Hans Huber: Bern, Germany, 1995.
Hinz A, Zweynert U, Kittel J, Igl W, Schwarz R . Veränderungsmessung mit der Hospital Anxiety and Depression Scale (HADS): Änderungssensitivität und Änderungsreliabilität. Psychother Psychos Med Psychol 2009; 59: 394–400.
Randolph JJ, Falbe K, Manuel AK, Balloun JL . A step-by-step guide to propensity score matching in R. Pract Assess Res Eval 2014; 19: 380–92.
Lee SJ, Loberiza FR, Antin JH, Kirkpatrick T, Prokop L, Alyea EP et al. Routine screening for psychosocial distress following hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 77–83.
Syrjala KL, Chapko M, Vitaliano P, Cummings C, Sullivan K . Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.
Beck AT, Steer RA, Brown GK . Manual for the Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX, USA, 1996.
Derogatis LR, Savitz KL . The SCL–90–R and Brief Symptom Inventory (BSI) in Primary Care. Lawrence Erlbaum Associates Publishers, 2000.
Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM et al. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 2007; 39: 759–766.
Trask PC, Paterson A, Riba M, Brines B, Griffith K, Parker P et al. Assessment of psychological distress in prospective bone marrow transplant patients. Bone Marrow Transplant 2002; 29: 917–925.
Dalton SO, Laursen TM, Ross L, Mortensen PB, Johansen C . Risk for hospitalization with depression after a cancer diagnosis: a nationwide, population-based study of cancer patients in Denmark From 1973 to 2003. J Clin Oncol 2009; 27: 1440–1445.
Balfour J, Kaplan G . Social class/socioeconomic factors. In: JC Holland (ed). Psycho-Oncology, 1998, pp 78–90.
Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014; 32: 3540–3546.
First MB. Structured clinical interview for the DSM (SCID). In: Cautin RL, Lilienfeld SO (eds). The Encyclopedia of Clinical Psychology. John Wiley & Sons Inc: Hoboken, NJ, USA, 2014, pp 1–6..
Andrykowski MA . Depression and survival after hematopoietic stem cell transplantation: where do we go from here? J Clin Oncol 2005; 23: 5878–5880.
Acknowledgements
This work was supported by the José Carreras Leukämie-Stiftung (grants DJCLS R 04/29pf, DJCLS R 07/37pf and DJCLS R 10/38p).
Author contributions
AS, LS, AS, LS and MK performed the research. AS, AM, UK, FS-K and AZ designed the research study. AZ and NK contributed essential reagents or tools. KK and PE analyzed the data. All authors wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Kuba, K., Esser, P., Mehnert, A. et al. Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany. Bone Marrow Transplant 52, 1651–1657 (2017). https://doi.org/10.1038/bmt.2017.190
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2017.190